Medicine and Dentistry
Prostate Cancer
100%
Radiation Therapy
80%
Bladder
39%
Neoplasm
34%
Diseases
31%
Malignant Neoplasm
29%
Head and Neck Cancer
26%
Biological Marker
22%
Xerostomia
21%
Radiomics
21%
Hormone Therapy
19%
Cystectomy
18%
Prevalence
16%
Odds Ratio
16%
Androgen Deprivation Therapy
16%
Docetaxel
15%
Urinary System
15%
Randomized Controlled Trial
15%
Zoledronic Acid
14%
Comet Assay
14%
Hypofractionated Radiotherapy
14%
Transitional Cell Carcinoma
14%
Germinoma
14%
Prostate Specific Antigen
14%
Bladder Cancer
12%
Muscle Invasive Bladder Cancer
12%
External Beam Radiotherapy
10%
Translational Research
10%
Neoadjuvant Chemotherapy
10%
Cancer Cell
10%
Recurrent Disease
10%
Parotid Gland
10%
Prostate Carcinoma
9%
Arm
8%
Prednisolone
8%
Hypoxia
8%
Overall Survival
7%
Quality of Life
7%
Metastatic Carcinoma
7%
Strontium 89
7%
Cost-Effectiveness Analysis
7%
Kidney Metastasis
7%
in Vivo Dosimetry
7%
Electronic Portal Imaging Device
7%
Tumor Spheroid
7%
Nephrectomy
7%
Androgen
7%
Dosimetry
7%
Bladder Capacity
7%
Surface-Enhanced Raman Spectroscopy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
65%
Neoplasm
33%
Diseases
23%
Prostate Specific Antigen
21%
Zoledronic Acid
21%
Chemotherapy
15%
Docetaxel
15%
Strontium 89
14%
Comet Assay
14%
Overall Survival
13%
Malignant Neoplasm
12%
Biological Marker
12%
Vasculotropin
10%
Kidney Cancer
9%
Prostate Carcinoma
9%
Endocrine Therapy
9%
Progression Free Survival
8%
Recurrent Disease
8%
Hypoxia
8%
Randomized Controlled Trial
8%
Androgen
7%
Abiraterone
7%
Cancer Model
7%
Peppermint
7%
Transitional Cell Carcinoma
7%
Nicotinamide
7%
Renal Cell Carcinoma
7%
Randomized Clinical Trial
7%
Cancer Staging
7%
Cediranib
7%
Non Insulin Dependent Diabetes Mellitus
7%
Bladder Tumor
7%
Tumor Microenvironment
7%
Kidney Metastasis
7%
Pregnancy Diabetes Mellitus
7%
Saracatinib
7%
Prevalence
5%